Sign in

CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
460574869
Phone
(857) 284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
  1. 8-K Event Results of operations
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. 4 Open-market sale See Remarks sold 15,843 shares at $3.84 ($60,915)
  11. 4 Planned sale President, CEO, and Chairman sold 56,910 shares at $3.85 ($218,819)
  12. 4 Open-market sale Chief Medical Officer sold 15,870 shares at $3.84 ($60,963)
  13. 4 Open-market sale EVP, Chief Accounting Officer sold 12,477 shares at $3.84 ($47,904)
  14. 4 Open-market sale Chief Commercial Officer sold 11,819 shares at $3.84 ($45,420)
  15. 4 Open-market sale Chief Development Officer sold 14,029 shares at $3.84 ($53,913)
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 7 of 16 · 316 filings